Rezvoglar Kwikpen Injection, Solution
Product Images NDC 50090-6439

Product Visual Gallery

This gallery contains 28 technical images submitted to the FDA as part of the official labeling for Rezvoglar Kwikpen (NDC 50090-6439). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label Image (Lbl500906439)

Label for REZVOGLAR KWIKPEN (insulin glargine-aglr) injection, solution, 100 units/mL, supplied as 5 prefilled pens. Label shows the NDC 50090-6439-0 and states the product is manufactured by A-S Medication Solutions in Libertyville, Illinois. Storage instructions recommend refrigerating at 36 to 46 degrees Fahrenheit and protecting from direct heat and light.*

FDA Label Image

Figure (Rezvoglar Kpen 80u Ifu 0 V1)

An anatomical illustration showing recommended subcutaneous injection sites on a human figure. The labeled injection areas are the upper arms, stomach, and thighs, highlighted by shaded oval regions on each part.*

FDA Label Image

Figure (Rezvoglar Kpen 80u Ifu 1 V2)

An illustration labeling the parts of the REZVOGLAR KWIKPEN injection pen, showing components including the pen cap with cap clip, cartridge holder with rubber seal and plunger, pen body with label, and dose indicator featuring dose window and dose knob.*

FDA Label Image

Figure (Rezvoglar Kpen 80u Ifu 10 V1)

An instructional diagram showing a close-up view of a dose selector on the REZVOGLAR KWIKPEN insulin pen. The image highlights the dose window with numbers for setting doses, accompanied by an arrow pointing to the number 24, indicating how to set or read the dose amount on the pen.*

FDA Label Image

Figure (Rezvoglar Kpen 80u Ifu 11 V2)

Instructional illustration showing a person administering a subcutaneous injection into the abdominal area using a syringe or pen device. The image highlights the injection technique with emphasis on correct hand positioning and angle.*

FDA Label Image

Figure (Rezvoglar Kpen 80u Ifu 12 V1)

An instructional illustration showing a hand holding an injection pen with a red spiral arrow indicating a twisting or turning action, likely demonstrating how to prepare or use the pen device for injection.*

FDA Label Image

Figure (Rezvoglar Kpen 80u Ifu 13 V1)

REZVOGLAR KWIKPEN insulin glargine-aglr injection, solution in a prefilled pen device for subcutaneous use. The label indicates 100 units per mL concentration (U-100) and specifies it is for single patient use only. The device is white with dosing markings visible.*

FDA Label Image

Figure (Rezvoglar Kpen 80u Ifu 14 V1)

REZVOGLAR KWIKPEN insulin glargine-aglr injection, solution pen. The image shows a white injectable pen device with a dose selector visible on the right side and a label area for lot and expiration information near the center. The pen is designed for subcutaneous use and contains 100 units/mL strength.*

FDA Label Image

Figure (Rezvoglar Kpen 80u Ifu 15 V1)

An instructional diagram showing the proper way to attach or align a needle safety shield onto an insulin pen device. The image shows the shield positioned at the pen tip with an arrow pointing left, indicating the direction for removal or attachment.*

FDA Label Image

Figure (Rezvoglar Kpen 80u Ifu 16 V1)

An illustration of the REZVOGLAR KWIKPEN injection device displaying the pen's dose window and markings on the dial for insulin glargine-aglr subcutaneous injection, 100 units/mL concentration. The image shows the pen's outline, dose indicator, and dial for dose adjustment.*

FDA Label Image

Figure (Rezvoglar Kpen 80u Ifu 17 V1)

Illustration showing a person holding a REZVOGLAR KWIKPEN injection pen while cleaning the injection site or pen tip with a cloth or wipe. The figure focuses on the hands and the pen to demonstrate proper handling or preparation for subcutaneous injection.*

FDA Label Image

Figure (Rezvoglar Kpen 80u Ifu 18 V1)

An instructional illustration showing a hand holding a cap and pulling it off, indicated by a red arrow pointing upward and rotating. This likely depicts removing a cap from a small vial or container, relevant to medication preparation or use.*

FDA Label Image

Figure (Rezvoglar Kpen 80u Ifu 19 V1)

An instructional illustration showing a close-up of a needle cap labeled "Keep" with an arrow pointing left, adjacent to an insulin vial's opening. This likely depicts a step in preparing the injection device for use with the vial.*

FDA Label Image

Figure (Rezvoglar Kpen 80u Ifu 2 V1)

Illustration showing components of a pen needle, including the outer needle shield, inner needle shield, paper tab, and needle, with a note that needles are not included. Also depicts a dose knob with a green ring.*

FDA Label Image

Figure (Rezvoglar Kpen 80u Ifu 22 V1)

An illustration of a stopwatch showing 5 seconds, likely indicating a timing instruction associated with the REZVOGLAR KWIKPEN insulin glargine-aglr injection.*

FDA Label Image

Figure (Rezvoglar Kpen 80u Ifu 23 V1)

An instructional line drawing showing a person injecting a solution subcutaneously into their abdomen. The image illustrates the use of a syringe or pen device for a subcutaneous injection.*

FDA Label Image

Figure (Rezvoglar Kpen 80u Ifu 24 V1)

An instructional illustration showing a hand removing or placing a cap onto a container marked with a biohazard symbol, indicating proper handling or disposal associated with medical or pharmaceutical use.*

FDA Label Image

Figure (Rezvoglar Kpen 80u Ifu 25 V1)

Instructional illustration showing the removal of the protective cap from a prefilled syringe or pen device. The image features an arrow indicating the direction to pull the cap off the injection device.*

FDA Label Image

Figure (Rezvoglar Kpen 80u Ifu 26 V1)

An instructional illustration showing a hand holding a REZVOGLAR KWIKPEN injection pen with the cap being removed or placed on the pen, indicated by a curved arrow pointing away from the pen tip.*

FDA Label Image

Figure (Rezvoglar Kpen 80u Ifu 27 V1)

Illustration of the REZVOGLAR KWIKPEN injection device showing a cross-sectional view of the pen mechanism including the needle attachment, insulin cartridge labeled for 100 units/mL strength, and dosing dial with numerical markings from 0 to 1 for dose setting.*

FDA Label Image

Figure (Rezvoglar Kpen 80u Ifu 3 V1)

An instructional diagram showing how to remove a red cap from the tip of an injection pen. The image depicts an insulin injection pen with a red arrow indicating the direction to twist or pull off the protective cap from the needle area.*

FDA Label Image

Figure (Rezvoglar Kpen 80u Ifu 4 V1)

An instructional diagram illustrating the action of pulling a slider or tab upward on a device, possibly a step in preparing or using the REZVOGLAR KWIKPEN insulin injection pen.*

FDA Label Image

Figure (Rezvoglar Kpen 80u Ifu 5 V2)

An instructional diagram showing a syringe with a labeled 'Throw Away' indicator, accompanied by an arrow pointing to the left, suggesting proper disposal direction or method for the syringe or pen needle.*

FDA Label Image

Figure (Rezvoglar Kpen 80u Ifu 6 V1)

An instructional diagram showing a hand holding the REZVOGLAR KWIKPEN injection device, indicating a downward pressing action on the pen's bottom button. A close-up inset highlights the needle attached to the pen, demonstrating proper needle placement or attachment for subcutaneous injection of insulin glargine-aglr 100 units/mL solution.*

FDA Label Image

Figure (Rezvoglar Kpen 80u Ifu 7 V1)

An illustration of a section of a REZVOGLAR KWIKPEN injection device showing the dosage selector window. Visible are the dosage markings and a red indicator line, demonstrating the dose-setting mechanism of the insulin glargine-aglr subcutaneous injection pen.*

FDA Label Image

Figure (Rezvoglar Kpen 80u Ifu 8 V1)

Illustration showing a hand holding the REZVOGLAR KWIKPEN insulin injection device with an arrow indicating upward movement, likely demonstrating part of the preparation or injection process for the insulin glargine-aglr solution.*

FDA Label Image

Figure (Rezvoglar Kpen 80u Ifu 9 V1)

An instructional diagram showing a close-up of a dosing window on a pen injector device. The window displays the number 12, and an arrow points downward toward the number, indicating dose selection or adjustment on the device.*

FDA Label Image

Figure 1 (Rezvoglar Uspi F1)

A line graph comparing glucose infusion rates (mg/kg/min) over time (hours) after subcutaneous injection of insulin glargine and NPH insulin. The graph shows a solid line for insulin glargine with a relatively stable glucose infusion rate and a dashed line for NPH insulin with a peak earlier in the observation period, marked by a triangle indicating the end of the observation at 24 hours.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.